Global Medical Breakthrough: Groundbreaking Thrombectomy Device Set to Revolutionize International Markets

PLEASANTON, Calif., Sept. 11, 2024 /PRNewswire/ -- FlowPhysixTM Inc, formerly known as Expanse ICE, is pleased to announce a strategic partnership with 3comma Medical / 3comma Medical GmbH who will serve as the international commercial partner for the FLOWRUNNERTM Aspiration Thrombectomy Device.

The FLOWRUNNER is an innovative, advanced device designed to facilitate the efficient removal of blood clots, providing hope for individuals suffering from vascular diseases and conditions worldwide. By virtue of this strategic partnership, FlowPhysix Inc aims to extend its global reach and accelerate the international distribution of the FLOWRUNNER.

'We are thrilled to have partnered with 3comma Medical GmbH and collaborate on bringing this groundbreaking technology to a wider audience,' stated an executive at FlowPhysix Inc. 'Their extensive distribution network and proven track record of success in launching medical innovations globally align with our own vision of transforming the field of vascular diseases and saving thousands of lives.'

FlowPhysix Inc. prides itself on delivering solutions that benefit patients, clinicians, and healthcare systems, leveraging the power of medical device innovation to address unmet needs and uncover new possibilities for treating complex diseases.

As the international landscape of cardiovascular and vascular diseases continues to evolve, necessitating advanced, innovative, and accessible medical treatments, the synergistic partnership between FlowPhysix Inc and 3comma Medical GmbH seeks to spearhead that progress. Together, both the American-based FlowPhysix Inc and 3comma Medical GmbH of Europe intend to make available this novel thrombectomy device to healthcare institutions around the world.

For more information about this partnership and the FLOWRUNNER technology itself, please contact FlowPhysix Inc or visit their official website.